T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Cannae Holdings
CNNE
$675M
| $641K | ﹤0.01% |
33,123
-7,557
| -19% | -$159K |
|
2102
Methode Electronics
MEI
$593M
| $641K | ﹤0.01% |
17,311
+179
| +1% | +$7.72K |
|
2103
iShares Core Dividend Growth ETF
DGRO
$43.9B
| $640K | ﹤0.01% |
13,439
| – | – |
|
2104
Liberty Latin America Class C
LILAK
$1.65B
| $640K | ﹤0.01% |
90,440
+832
| +0.9% | +$6.91K |
|
|
NOVA
2105
DELISTED
Sunnova Energy
NOVA
| $639K | ﹤0.01% |
34,673
+4,190
| +14% | +$80.1K |
|
2106
Warrior Met Coal
HCC
$4.98B
| $638K | ﹤0.01% |
20,837
-495
| -2% | -$17.1K |
|
2107
FuelCell Energy
FCEL
$1.63B
| $637K | ﹤0.01% |
5,664
+905
| +19% | +$114K |
|
|
UDMY
2108
DELISTED
Udemy
UDMY
| $637K | ﹤0.01% |
+62,426
| New | +$756K |
|
2109
JFrog
FROG
$11.5B
| $636K | ﹤0.01% |
30,202
-4,733
| -14% | -$99.3K |
|
2110
NMI Holdings
NMIH
$3.42B
| $636K | ﹤0.01% |
38,189
+2,918
| +8% | +$53K |
|
|
HDSN
2111
Hudson Technologies
HDSN
$239M
| $632K | ﹤0.01% |
84,137
+47,177
| +128% | +$389K |
|
2112
TripAdvisor
TRIP
$1.29B
| $632K | ﹤0.01% |
35,478
-799
| -2% | -$18.9K |
|
|
TWOU
2113
DELISTED
2U Inc
TWOU
| $627K | ﹤0.01% |
1,996
+188
| +10% | +$58K |
|
2114
Ligand Pharmaceuticals
LGND
$5.76B
| $624K | ﹤0.01% |
11,210
-1,819
| -14% | -$103K |
|
2115
Nicolet Bankshares
NIC
$3.73B
| $624K | ﹤0.01% |
8,630
+101
| +1% | +$8.17K |
|
2116
AdaptHealth
AHCO
$760M
| $623K | ﹤0.01% |
34,515
+7,977
| +30% | +$130K |
|
2117
Cracker Barrel
CBRL
$1.31B
| $621K | ﹤0.01% |
7,436
+86
| +1% | +$8.93K |
|
2118
Extreme Networks
EXTR
$3.16B
| $621K | ﹤0.01% |
69,643
+885
| +1% | +$8.99K |
|
2119
MBIA
MBI
$262M
| $621K | ﹤0.01% |
50,246
-11,491
| -19% | -$151K |
|
|
TSE
2120
DELISTED
Trinseo
TSE
| $621K | ﹤0.01% |
16,151
+510
| +3% | +$23.1K |
|
|
CNR
2121
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $621K | ﹤0.01% |
25,368
-7,373
| -23% | -$180K |
|
|
VIA
2122
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $620K | ﹤0.01% |
16,177
+1,480
| +10% | +$58.1K |
|
2123
Brookdale Senior Living
BKD
$3B
| $618K | ﹤0.01% |
136,161
+1,329
| +1% | +$7.85K |
|
2124
Veracyte
VCYT
$3.42B
| $618K | ﹤0.01% |
31,036
+2,537
| +9% | +$51.3K |
|
2125
SelectQuote
SLQT
$126M
| $617K | ﹤0.01% |
248,684
+37,200
| +18% | +$95.4K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.